{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T19:45:30Z","timestamp":1790192730626,"version":"4.1.0"},"reference-count":97,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100002426","name":"Telethon","doi-asserted-by":"publisher","award":["GGP06019"],"award-info":[{"award-number":["GGP06019"]}],"id":[{"id":"10.13039\/501100002426","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002426","name":"Telethon","doi-asserted-by":"publisher","award":["GGP09018"],"award-info":[{"award-number":["GGP09018"]}],"id":[{"id":"10.13039\/501100002426","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002426","name":"Telethon","doi-asserted-by":"publisher","award":["GGP14014"],"award-info":[{"award-number":["GGP14014"]}],"id":[{"id":"10.13039\/501100002426","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Union","doi-asserted-by":"crossref","award":["602300"],"award-info":[{"award-number":["602300"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000780","name":"European Union","doi-asserted-by":"crossref","award":["690850"],"award-info":[{"award-number":["690850"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Horizon Pharma Ireland Ltd"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bone"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1016\/j.bone.2017.02.002","type":"journal-article","created":{"date-parts":[[2017,2,4]],"date-time":"2017-02-04T09:47:28Z","timestamp":1486201648000},"page":"50-59","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":63,"special_numbering":"C","title":["Osteopetroses, emphasizing potential approaches to treatment"],"prefix":"10.1016","volume":"102","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5887-4419","authenticated-orcid":false,"given":"Anna","family":"Teti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0940-1911","authenticated-orcid":false,"given":"Michael J.","family":"Econs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bone.2017.02.002_bb0005","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.abb.2014.06.017","article-title":"The great beauty of the osteoclast","volume":"558","author":"Cappariello","year":"2014","journal-title":"Arch. Biochem. Biophys."},{"issue":"4","key":"10.1016\/j.bone.2017.02.002_bb0010","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1007\/s11914-011-0078-8","article-title":"Bone development: overview of bone cells and signalling","volume":"9","author":"Teti","year":"2011","journal-title":"Curr. Osteoporos. Rep."},{"issue":"1","key":"10.1016\/j.bone.2017.02.002_bb0015","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.bone.2007.08.029","article-title":"Genetics, pathogenesis and complications of osteopetrosis","volume":"42","author":"Del Fattore","year":"2008","journal-title":"Bone"},{"key":"10.1016\/j.bone.2017.02.002_bb0020","series-title":"Sclerosing Bone Disorders Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism","first-page":"769","author":"Whyte","year":"2013"},{"issue":"9","key":"10.1016\/j.bone.2017.02.002_bb0025","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1038\/nrendo.2013.137","article-title":"Osteopetrosis: genetics, treatment and new insights into osteoclast function","volume":"9","author":"Sobacchi","year":"2013","journal-title":"Nat. Rev. Endocrinol."},{"issue":"5","key":"10.1016\/j.bone.2017.02.002_bb0030","first-page":"A50","article-title":"Carbonic anhydrase type II deficiency","volume":"46","author":"Bolt","year":"2005","journal-title":"Am. J. Kidney Dis."},{"issue":"2","key":"10.1016\/j.bone.2017.02.002_bb0035","doi-asserted-by":"crossref","first-page":"R39","DOI":"10.1530\/EJE-13-0136","article-title":"Autosomal dominant osteopetrosis revisited: lessons from recent studies","volume":"169","author":"Bollerslev","year":"2013","journal-title":"Eur. J. Endocrinol."},{"issue":"25","key":"10.1016\/j.bone.2017.02.002_bb0040","doi-asserted-by":"crossref","first-page":"2861","DOI":"10.1093\/hmg\/10.25.2861","article-title":"Albers-Sch\u00f6nberg disease (autosomal dominant osteopetrosis, type II) results from mutations in the ClCN7 chloride channel gene","volume":"10","author":"Cleiren","year":"2001","journal-title":"Hum. Mol. Genet."},{"issue":"10","key":"10.1016\/j.bone.2017.02.002_bb0045","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1359\/jbmr.2003.18.10.1740","article-title":"Chloride channel ClCN7 mutations are responsible for severe recessive, dominant, and intermediate osteopetrosis","volume":"18","author":"Frattini","year":"2003","journal-title":"J. Bone Miner. Res."},{"issue":"4","key":"10.1016\/j.bone.2017.02.002_bb0050","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1007\/s00774-009-0051-0","article-title":"Identification of the CLCN7 gene mutations in two Chinese families with autosomal dominant osteopetrosis (type II)","volume":"27","author":"Zhang","year":"2009","journal-title":"J. Bone Miner. Metab."},{"issue":"1","key":"10.1016\/j.bone.2017.02.002_bb0055","doi-asserted-by":"crossref","first-page":"E1071","DOI":"10.1002\/humu.21167","article-title":"Molecular and clinical heterogeneity in CLCN7-dependent osteopetrosis: report of 20 novel mutations","volume":"31","author":"Pangrazio","year":"2010","journal-title":"Hum. Mutat."},{"issue":"3","key":"10.1016\/j.bone.2017.02.002_bb0060","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1007\/s00774-011-0319-z","article-title":"The virulence gene and clinical phenotypes of osteopetrosis in the Chinese population: six novel mutations of the CLCN7 gene in twelve osteopetrosis families","volume":"30","author":"Wang","year":"2012","journal-title":"J. Bone Miner. Metab."},{"issue":"4","key":"10.1016\/j.bone.2017.02.002_bb0065","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0899-7071(96)00051-4","article-title":"Epiphyseal growth arrest lines. MR findings","volume":"21","author":"Yao","year":"1997","journal-title":"Clin. Imaging"},{"key":"10.1016\/j.bone.2017.02.002_bb0070","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1111\/j.1749-6632.2009.05244.x","article-title":"Heritable sclerosing bone disorders: presentation and new molecular mechanisms","volume":"1192","author":"de Vernejoul","year":"2010","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.bone.2017.02.002_bb0075","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1038\/sj.bmt.1704194","article-title":"Long-term outcome of haematopoietic stem cell transplantation in autosomal recessive osteopetrosis: an EBMT report","volume":"32","author":"Driessen","year":"2003","journal-title":"Bone Marrow Transplant."},{"issue":"2","key":"10.1016\/j.bone.2017.02.002_bb0080","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0092-8674(01)00206-9","article-title":"Loss of the ClC7 chloride channel leads to osteopetrosis in mice and man","volume":"104","author":"Kornak","year":"2001","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.bone.2017.02.002_bb0085","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/nm842","article-title":"Grey-lethal mutation induces severe malignant autosomal recessive osteopetrosis in mouse and human","volume":"9","author":"Chalhoub","year":"2003","journal-title":"Nat. Med."},{"key":"10.1016\/j.bone.2017.02.002_bb0090","series-title":"Stem Cells and Bone Diseases","first-page":"267","article-title":"Chapter 15. Haematopoietic stem cell transplantation in autosomal recessive osteopetrosis","author":"Teti","year":"2013"},{"issue":"6","key":"10.1016\/j.bone.2017.02.002_bb0095","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1038\/nm.1963","article-title":"Impaired gastric acidification negatively affects calcium homeostasis and bone mass","volume":"15","author":"Schinke","year":"2009","journal-title":"Nat. Med."},{"issue":"4","key":"10.1016\/j.bone.2017.02.002_bb0100","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1002\/jbmr.2100","article-title":"CLCN7 and TCIRG1 mutations differentially affect bone matrix mineralization in osteopetrotic individuals","volume":"29","author":"Barvencik","year":"2014","journal-title":"J. Bone Miner. Res."},{"issue":"3","key":"10.1016\/j.bone.2017.02.002_bb0105","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1005057","article-title":"Osteopetrorickets due to Snx10 deficiency in mice results from both failed osteoclast activity and loss of gastric acid-dependent calcium absorption","volume":"11","author":"Ye","year":"2015","journal-title":"PLoS Genet."},{"issue":"8","key":"10.1016\/j.bone.2017.02.002_bb0110","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1038\/ng2076","article-title":"Osteoclast-poor human osteopetrosis due to mutations in the gene encoding RANKL","volume":"39","author":"Sobacchi","year":"2007","journal-title":"Nat. Genet."},{"issue":"1","key":"10.1016\/j.bone.2017.02.002_bb0115","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.ajhg.2008.06.015","article-title":"Human osteoclast-poor osteopetrosis with hypogammaglobulinemia due to TNFRSF11A (RANK) mutations","volume":"83","author":"Guerrini","year":"2008","journal-title":"Am. J. Hum. Genet."},{"issue":"1","key":"10.1016\/j.bone.2017.02.002_bb0120","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00223-008-9196-4","article-title":"Infantile malignant, autosomal recessive osteopetrosis: the rich and the poor","volume":"84","author":"Villa","year":"2009","journal-title":"Calcif. Tissue Int."},{"issue":"4","key":"10.1016\/j.bone.2017.02.002_bb0125","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1136\/jmg.2005.036673","article-title":"Clinical, genetic, and cellular analysis of 49 osteopetrotic patients: implications for diagnosis and treatment","volume":"43","author":"Del Fattore","year":"2006","journal-title":"J. Med. Genet."},{"issue":"1","key":"10.1016\/j.bone.2017.02.002_bb0130","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/0887-8994(87)90057-9","article-title":"Creatine kinase brain isoenzyme in infantile osteopetrosis","volume":"3","author":"Hiroyama","year":"1987","journal-title":"Pediatr. Neurol."},{"issue":"3","key":"10.1016\/j.bone.2017.02.002_bb0135","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1542\/peds.77.3.371","article-title":"Carbonic anhydrase II deficiency syndrome: recessive osteopetrosis with renal tubular acidosis and cerebral calcification","volume":"77","author":"Ohlsson","year":"1986","journal-title":"Pediatrics"},{"issue":"2","key":"10.1016\/j.bone.2017.02.002_bb0140","doi-asserted-by":"crossref","first-page":"415S","DOI":"10.1093\/jn\/138.2.415S","article-title":"Extracellular pH regulates bone cell function","volume":"138","author":"Arnett","year":"2008","journal-title":"J. Nutr."},{"issue":"3","key":"10.1016\/j.bone.2017.02.002_bb0145","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1086\/368277","article-title":"Six novel missense mutations in the LDL receptor-related protein 5 (LRP5) gene in different conditions with an increased bone density","volume":"72","author":"Van Wesenbeeck","year":"2003","journal-title":"Am. J. Hum. Genet."},{"issue":"3","key":"10.1016\/j.bone.2017.02.002_bb0150","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.bone.2011.05.006","article-title":"Identification of the first deletion in the LRP5 gene in a patient with autosomal dominant osteopetrosis type I","volume":"49","author":"Pangrazio","year":"2011","journal-title":"Bone"},{"issue":"3","key":"10.1016\/j.bone.2017.02.002_bb0155","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1210\/jc.2006-1986","article-title":"Autosomal dominant osteopetrosis: clinical severity and natural history of 94 subjects with a chloride channel 7 gene mutation","volume":"92","author":"Waguespack","year":"2007","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"10.1016\/j.bone.2017.02.002_bb0160","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S8756-3282(99)00244-6","article-title":"Type II autosomal dominant osteopetrosis (Albers-Sch\u00f6nberg disease): clinical and radiological manifestations in 42 patients","volume":"26","author":"B\u00e9nichou","year":"2000","journal-title":"Bone"},{"issue":"6","key":"10.1016\/j.bone.2017.02.002_bb0165","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1007\/BF02556458","article-title":"Elevated serum levels of creatine kinase BB in autosomal dominant osteopetrosis type II","volume":"48","author":"Gram","year":"1991","journal-title":"Calcif. Tissue Int."},{"issue":"10","key":"10.1016\/j.bone.2017.02.002_bb0170","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1002\/jbmr.5650111010","article-title":"Creatine kinase brain isoenzyme (BB-CK) presence in serum distinguishes osteopetroses among the sclerosing bone disorders","volume":"11","author":"Whyte","year":"1996","journal-title":"J. Bone Miner. Res."},{"issue":"1","key":"10.1016\/j.bone.2017.02.002_bb0175","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/aja.1001610102","article-title":"The hematogenous origin of osteoclasts: experimental evidence from osteopetrotic (microphthalmic) mice treated with spleen cells from beige mouse donors","volume":"161","author":"Marks","year":"1981","journal-title":"Am. J. Anat."},{"key":"10.1016\/j.bone.2017.02.002_bb0180","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1097\/00003086-198201000-00001","article-title":"The classic: osteopetrosis cured by temporary parabiosis","volume":"162","author":"Walker","year":"1982","journal-title":"Clin. Orthop. Relat. Res."},{"issue":"2","key":"10.1016\/j.bone.2017.02.002_bb0185","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1615\/CritRevEukaryotGeneExpr.v15.i2.40","article-title":"Lessons from osteopetrotic mutations in animals: impact on our current understanding of osteoclast biology","volume":"15","author":"Van Wesenbeeck","year":"2005","journal-title":"Crit. Rev. Eukaryot. Gene Expr."},{"issue":"3","key":"10.1016\/j.bone.2017.02.002_bb0190","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S8756-3282(99)00278-1","article-title":"The gene encoding the mouse homologue of the human osteoclast-specific 116-kDa V-ATPase subunit bears a deletion in osteosclerotic (oc\/oc) mutants","volume":"26","author":"Scimeca","year":"2000","journal-title":"Bone"},{"issue":"4","key":"10.1016\/j.bone.2017.02.002_bb0195","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1172\/JCI30328","article-title":"Involvement of PLEKHM1 in osteoclastic vesicular transport and osteopetrosis in incisors absent rats and humans","volume":"117","author":"Van Wesenbeeck","year":"2007","journal-title":"J. Clin. Invest."},{"issue":"4","key":"10.1016\/j.bone.2017.02.002_bb0200","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/0092-8674(91)90499-O","article-title":"Targeted disruption of the c-src proto-oncogene leads to osteopetrosis in mice","volume":"64","author":"Soriano","year":"1991","journal-title":"Cell"},{"key":"10.1016\/j.bone.2017.02.002_bb0205","doi-asserted-by":"crossref","first-page":"10905e10","DOI":"10.1073\/pnas.200294797","article-title":"Diverse roles of the tumor necrosis factor family member TRANCE in skeletal physiology revealed by TRANCE deficiency and partial rescue by a lymphocyte-expressed TRANCE transgene","volume":"97","author":"Kim","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bone.2017.02.002_bb0210","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0002-9440(10)63798-4","article-title":"Genotype-phenotype relationship in human ATP6i-dependent autosomal recessive osteopetrosis","volume":"62","author":"Taranta","year":"2003","journal-title":"Am. J. Pathol."},{"issue":"6","key":"10.1016\/j.bone.2017.02.002_bb0215","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1002\/jemt.10375","article-title":"Osteoclast diseases","volume":"61","author":"Helfrich","year":"2003","journal-title":"Microsc. Res. Tech."},{"issue":"6","key":"10.1016\/j.bone.2017.02.002_bb0220","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1002\/jbmr.324","article-title":"Parathyroid hormone regulates the distribution and osteoclastogenic potential of hematopoietic progenitors in the bone marrow","volume":"26","author":"Jacome-Galarza","year":"2011","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2017.02.002_bb0225","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.semcdb.2015.11.006","article-title":"Calcium-sensing receptor, proinflammatory cytokines and calcium homeostasis","volume":"49","author":"Hendy","year":"2016","journal-title":"Semin. Cell Dev. Biol."},{"issue":"10","key":"10.1016\/j.bone.2017.02.002_bb0230","first-page":"801","article-title":"Catabolic and anabolic actions of parathyroid hormone on the skeleton","volume":"34","author":"Silva","year":"2011","journal-title":"J. Endocrinol. Investig."},{"issue":"5","key":"10.1016\/j.bone.2017.02.002_bb0235","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1359\/jbmr.081237","article-title":"Beta-Arrestin2 regulates RANKL and ephrins gene expression in response to bone remodeling in mice","volume":"24","author":"Pierroz","year":"2009","journal-title":"J. Bone Miner. Res."},{"issue":"5","key":"10.1016\/j.bone.2017.02.002_bb0240","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1016\/S0002-9440(10)63712-1","article-title":"Characterization of osteoclasts from patients harboring a G215R mutation in ClC-7 causing autosomal dominant osteopetrosis type II","volume":"164","author":"Henriksen","year":"2004","journal-title":"Am. J. Pathol."},{"issue":"2","key":"10.1016\/j.bone.2017.02.002_bb0245","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/S0002-9440(10)62269-9","article-title":"Acidification of the osteoclastic resorption compartment provides insight into the coupling of bone formation to bone resorption","volume":"166","author":"Karsdal","year":"2005","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.bone.2017.02.002_bb0250","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1038\/bonekey.2012.46","article-title":"Osteoclasts and hematopoiesis","volume":"1","author":"Teti","year":"2012","journal-title":"BoneKey Rep."},{"issue":"3","key":"10.1016\/j.bone.2017.02.002_bb0255","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/77131","article-title":"Defects in TCIRG1 subunit of the vacuolar proton pump are responsible for a subset of human autosomal recessive osteopetrosis","volume":"25","author":"Frattini","year":"2000","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bone.2017.02.002_bb0260","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.matbio.2016.02.009","article-title":"The \u201clove-hate\u201d relationship between osteoclasts and bone matrix","volume":"52\u201354","author":"Rucci","year":"2016","journal-title":"Matrix Biol."},{"issue":"11","key":"10.1016\/j.bone.2017.02.002_bb0265","doi-asserted-by":"crossref","first-page":"2140","DOI":"10.1038\/emboj.2011.137","article-title":"ClC-7 is a slowly voltage-gated 2Cl(\u2212)\/1H(+)-exchanger and requires Ostm1 for transport activity","volume":"30","author":"Leisle","year":"2011","journal-title":"EMBO J."},{"issue":"4","key":"10.1016\/j.bone.2017.02.002_bb0270","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1136\/jmedgenet-2011-100520","article-title":"An SNX10 mutation causes malignant osteopetrosis of infancy","volume":"49","author":"Aker","year":"2012","journal-title":"J. Med. Genet."},{"issue":"2","key":"10.1016\/j.bone.2017.02.002_bb0275","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1002\/jbmr.559","article-title":"RANK-dependent autosomal recessive osteopetrosis: characterization of five new cases with novel mutations","volume":"27","author":"Pangrazio","year":"2012","journal-title":"J. Bone Miner. Res."},{"issue":"3","key":"10.1016\/j.bone.2017.02.002_bb0280","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/85837","article-title":"X-linked anhidrotic ectodermal dysplasia with immunodeficiency is caused by impaired NF-kappaB signaling","volume":"27","author":"D\u00f6ffinger","year":"2001","journal-title":"Nat. Genet."},{"issue":"6","key":"10.1016\/j.bone.2017.02.002_bb0285","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1002\/jcb.22364","article-title":"Impediment of NEMO oligomerization inhibits osteoclastogenesis and osteolysis","volume":"108","author":"Darwech","year":"2009","journal-title":"J. Cell. Biochem."},{"issue":"4","key":"10.1016\/j.bone.2017.02.002_bb0290","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1080\/15548627.2015.1034419","article-title":"PLEKHM1: ADAPTING to life at the lysosome","volume":"11","author":"McEwan","year":"2015","journal-title":"Autophagy"},{"issue":"7","key":"10.1016\/j.bone.2017.02.002_bb0295","doi-asserted-by":"crossref","first-page":"3071","DOI":"10.1073\/pnas.1014293108","article-title":"Intramolecular proton shuttle supports not only catalytic but also noncatalytic function of carbonic anhydrase II","volume":"108","author":"Becker","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1","key":"10.1016\/j.bone.2017.02.002_bb0300","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1172\/JCI113863","article-title":"Cytoplasmic pH regulation and chloride\/bicarbonate exchange in avian osteoclasts","volume":"83","author":"Teti","year":"1989","journal-title":"J. Clin. Invest."},{"issue":"14","key":"10.1016\/j.bone.2017.02.002_bb0305","doi-asserted-by":"crossref","first-page":"5278","DOI":"10.1073\/pnas.87.14.5278","article-title":"Functional expression and subcellular localization of an anion exchanger cloned from choroid plexus","volume":"87","author":"Lindsey","year":"1990","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"2","key":"10.1016\/j.bone.2017.02.002_bb0310","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1136\/jmg.40.2.115","article-title":"A phenocopy of CAII deficiency: a novel genetic explanation for inherited infantile osteopetrosis with distal renal tubular acidosis","volume":"40","author":"Borthwick","year":"2003","journal-title":"J. Med. Genet."},{"issue":"1","key":"10.1016\/j.bone.2017.02.002_bb0315","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/S0167-4781(99)00128-1","article-title":"Complete genomic structure of the CLCN6 and CLCN7 putative chloride channel genes(1)","volume":"1447","author":"Kornak","year":"1999","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bone.2017.02.002_bb0320","doi-asserted-by":"crossref","first-page":"16035","DOI":"10.1038\/boneres.2016.35","article-title":"Enhanced but hypofunctional osteoclastogenesis in an autosomal dominant osteopetrosis type II case carrying a c.1856C>T mutation in CLCN7","volume":"4","author":"Chen","year":"2016","journal-title":"Bone Res."},{"key":"10.1016\/j.bone.2017.02.002_bb0325","doi-asserted-by":"crossref","DOI":"10.1177\/1744806916652628","article-title":"Novel CLCN7 mutation identified in a Han Chinese family with autosomal dominant osteopetrosis-2","volume":"12","author":"Deng","year":"2016","journal-title":"Mol. Pain"},{"issue":"3","key":"10.1016\/j.bone.2017.02.002_bb0330","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1007\/s00198-015-3320-x","article-title":"Novel mutations of CLCN7 cause autosomal dominant osteopetrosis type II (ADO-II) and intermediate autosomal recessive osteopetrosis (IARO) in Chinese patients","volume":"27","author":"Pang","year":"2016","journal-title":"Osteoporos. Int."},{"issue":"4","key":"10.1016\/j.bone.2017.02.002_bb0335","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1007\/s00774-015-0682-2","article-title":"Two novel mutations of CLCN7 gene in Chinese families with autosomal dominant osteopetrosis (type II)","volume":"34","author":"Zheng","year":"2016","journal-title":"J. Bone Miner. Metab."},{"issue":"2","key":"10.1016\/j.bone.2017.02.002_bb0340","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.jbspin.2013.06.014","article-title":"Identification of two novel CLCN7 gene mutations in three Chinese families with autosomal dominant osteopetrosis type II","volume":"81","author":"Zheng","year":"2014","journal-title":"Joint Bone Spine"},{"issue":"6","key":"10.1016\/j.bone.2017.02.002_bb0345","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/j.bone.2008.07.249","article-title":"CLCN7 polymorphisms and bone mineral density in healthy premenopausal white women and in white men","volume":"43","author":"Chu","year":"2008","journal-title":"Bone"},{"issue":"3","key":"10.1016\/j.bone.2017.02.002_bb0350","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1210\/jc.2005-2017","article-title":"Polymorphisms in the CLCN7 gene modulate bone density in postmenopausal women and in patients with autosomal dominant osteopetrosis type II","volume":"91","author":"Kornak","year":"2006","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"11","key":"10.1016\/j.bone.2017.02.002_bb0355","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1359\/JBMR.050717","article-title":"Polymorphisms of the CLCN7 gene are associated with BMD in women","volume":"20","author":"Pettersson","year":"2005","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2017.02.002_bb0360","first-page":"HT1","article-title":"Storage disease and neurological phenotype in autosomal dominant osteopetrosis type 2 (ADO2). A preclinical study","volume":"5","author":"Maurizi","year":"2016","journal-title":"Bone Abstr."},{"key":"10.1016\/j.bone.2017.02.002_bb0365","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.bone.2013.10.021","article-title":"Generation of the first autosomal dominant osteopetrosis type II (ADO2) disease models","volume":"59","author":"Alam","year":"2014","journal-title":"Bone"},{"issue":"4216","key":"10.1016\/j.bone.2017.02.002_bb0370","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1126\/science.1105786","article-title":"Bone resorption restored in osteopetrotic mice by transplants of normal bone marrow and spleen cells","volume":"190","author":"Walker","year":"1975","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.bone.2017.02.002_bb0375","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1006\/bbrc.1999.0252","article-title":"A new member of tumor necrosis factor ligand family, ODF\/OPGL\/TRANCE\/RANKL, regulates osteoclast differentiation and function","volume":"256","author":"Takahashi","year":"1999","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"6","key":"10.1016\/j.bone.2017.02.002_bb0380","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1242\/dev.102210","article-title":"Skeletal stem cells","volume":"142","author":"Bianco","year":"2015","journal-title":"Development"},{"issue":"1","key":"10.1016\/j.bone.2017.02.002_bb0385","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s13045-016-0276-z","article-title":"The clinical application of mesenchymal stromal cells in hematopoietic stem cell transplantation","volume":"9","author":"Zhao","year":"2016","journal-title":"J. Hematol. Oncol."},{"issue":"1","key":"10.1016\/j.bone.2017.02.002_bb0390","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jcyt.2016.09.008","article-title":"The exciting prospects of new therapies with mesenchymal stromal cells","volume":"19","author":"Prockop","year":"2017","journal-title":"Cytotherapy"},{"key":"10.1016\/j.bone.2017.02.002_bb0395","article-title":"Concise review: mesenchymal stem cell therapy for pediatric disease: perspectives on success and potential improvements","author":"Nitkin","year":"2016","journal-title":"Stem Cells Transl. Med."},{"key":"10.1016\/j.bone.2017.02.002_bb0400","doi-asserted-by":"crossref","first-page":"223","DOI":"10.3389\/fphar.2014.00223","article-title":"Prenatal transplantation of mesenchymal stem cells to treat osteogenesis imperfecta","volume":"5","author":"Chan","year":"2014","journal-title":"Front. Pharmacol."},{"issue":"12","key":"10.1016\/j.bone.2017.02.002_bb0405","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.2217\/imt-2016-0098","article-title":"Mesenchymal stromal cells with enhanced therapeutic properties","volume":"8","author":"Girdlestone","year":"2016","journal-title":"Immunotherapy"},{"issue":"11","key":"10.1016\/j.bone.2017.02.002_bb0410","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.1097\/TP.0000000000001029","article-title":"The potential of mesenchymal stromal cells as treatment for severe steroid-refractory acute graft-versus-host disease: a critical review of the literature","volume":"100","author":"Munneke","year":"2016","journal-title":"Transplantation"},{"key":"10.1016\/j.bone.2017.02.002_bb0415","author":"Schulz"},{"issue":"24","key":"10.1016\/j.bone.2017.02.002_bb0420","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1056\/NEJM199506153322402","article-title":"Long-term treatment of osteopetrosis with recombinant human interferon gamma","volume":"332","author":"Key","year":"1995","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bone.2017.02.002_bb0425","first-page":"2015","article-title":"Recurrent osteomyelitis of the mandible in osteopetrosis: a common complication of an uncommon disease","volume":"8","author":"Saigal","year":"2015","journal-title":"BMJ Case Rep."},{"issue":"2","key":"10.1016\/j.bone.2017.02.002_bb0430","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/0221-8747(81)90033-3","article-title":"Induction of bone resorption by parathyroid hormone in congenital malignant osteopetrosis","volume":"3","author":"Glorieux","year":"1981","journal-title":"Metab. Bone Dis. Relat. Res."},{"issue":"1","key":"10.1016\/j.bone.2017.02.002_bb0435","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1056\/NEJM198407053110116","article-title":"Brown DM calcitriol for congenital osteopetrosis","volume":"311","author":"Blazar","year":"1984","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bone.2017.02.002_bb0440","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1097\/00003086-199309000-00010","article-title":"Osteopetrosis. The pharmaco-physiologic basis of therapy","volume":"294","author":"Key","year":"1993","journal-title":"Clin. Orthop. Relat. Res."},{"issue":"3","key":"10.1016\/j.bone.2017.02.002_bb0445","doi-asserted-by":"crossref","first-page":"150","DOI":"10.2174\/156652309788488613","article-title":"Prospects for gene therapy of osteopetrosis","volume":"9","author":"Askmyr","year":"2009","journal-title":"Curr. Gene Ther."},{"key":"10.1016\/j.bone.2017.02.002_bb0450","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(16)30374-9","article-title":"Lentiviral haemopoietic stem-cell gene therapy in early-onset metachromatic leukodystrophy: an ad-hoc analysis of a non-randomised, open-label, phase 1\/2 trial","author":"Sessa","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.bone.2017.02.002_bb0455","doi-asserted-by":"crossref","DOI":"10.1074\/jbc.M116.719237","article-title":"Combining single-strand oligodeoxynucleotides and CRISPR\/Cas9 to correct gene mutations in Beta-thalassemia-induced Pluripotent Stem Cells","author":"Niu","year":"2016","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.bone.2017.02.002_bb0460","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.stemcr.2015.08.005","article-title":"Targeted gene correction in osteopetrotic-induced pluripotent stem cells for the generation of functional osteoclasts","volume":"5","author":"Neri","year":"2015","journal-title":"Stem Cell Rep."},{"issue":"4","key":"10.1016\/j.bone.2017.02.002_bb0465","doi-asserted-by":"crossref","DOI":"10.3390\/cells5040044","article-title":"Potential of induced pluripotent stem cells (iPSCs) for treating age-related macular degeneration (AMD)","volume":"5","author":"Fields","year":"2016","journal-title":"Cells"},{"issue":"12","key":"10.1016\/j.bone.2017.02.002_bb0470","doi-asserted-by":"crossref","first-page":"2501","DOI":"10.1002\/jbmr.1712","article-title":"Osteopetrosis rescue upon RANKL administration to Rankl(\u2212\/\u2212) mice: a new therapy for human RANKL-dependent ARO","volume":"27","author":"Lo Iacono","year":"2012","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2017.02.002_bb0475","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.biomaterials.2014.12.033","article-title":"Biotechnological approach for systemic delivery of membrane receptor activator of NF-\u03baB ligand (RANKL) active domain into the circulation","volume":"46","author":"Cappariello","year":"2015","journal-title":"Biomaterials"},{"key":"10.1016\/j.bone.2017.02.002_bb0480","doi-asserted-by":"crossref","DOI":"10.1038\/mtna.2015.21","article-title":"Effective small interfering RNA therapy to treat CLCN7-dependent autosomal dominant osteopetrosis type 2","volume":"4","author":"Capulli","year":"2015","journal-title":"Mol. Ther.\u2013Nucleic Acids."},{"issue":"11","key":"10.1016\/j.bone.2017.02.002_bb0485","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1002\/jbmr.2545","article-title":"Interferon gamma, but not calcitriol improves the osteopetrotic phenotypes in ADO2 mice","volume":"30","author":"Alam","year":"2015","journal-title":"J. Bone Miner. Res."}],"container-title":["Bone"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328217300406?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328217300406?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,24]],"date-time":"2022-07-24T18:05:46Z","timestamp":1658685946000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S8756328217300406"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9]]},"references-count":97,"alternative-id":["S8756328217300406"],"URL":"https:\/\/doi.org\/10.1016\/j.bone.2017.02.002","relation":{},"ISSN":["8756-3282"],"issn-type":[{"value":"8756-3282","type":"print"}],"subject":[],"published":{"date-parts":[[2017,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Osteopetroses, emphasizing potential approaches to treatment","name":"articletitle","label":"Article Title"},{"value":"Bone","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bone.2017.02.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}